BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11294500)

  • 21. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
    Gyte A; Pritchard LE; Jones HB; Brennand JC; White A
    J Neuroendocrinol; 2007 Dec; 19(12):941-51. PubMed ID: 18001323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats.
    Pérez C; Fernández-Agulló T; De Solís AJ; Ros M; Andrés A; Carrascosa JM
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):256-61. PubMed ID: 18290871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
    Fugono J; Yasui H; Sakurai H
    J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes.
    Chavez M; Seeley RJ; Havel PJ; Friedman MI; Matson CA; Woods SC; Schwartz MW
    J Clin Invest; 1998 Jul; 102(2):340-6. PubMed ID: 9664075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression.
    Sipols AJ; Baskin DG; Schwartz MW
    Diabetes; 1995 Feb; 44(2):147-51. PubMed ID: 7859932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids.
    Dryden S; Burns SJ; Frankish HM; Williams G
    Eur J Pharmacol; 1997 Dec; 340(2-3):221-5. PubMed ID: 9537819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats.
    Lv WS; Wen JP; Li L; Sun RX; Wang J; Xian YX; Cao CX; Wang YL; Gao YY
    Brain Res; 2012 Mar; 1444():11-9. PubMed ID: 22325091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
    Majithiya JB; Balaraman R; Giridhar R; Yadav MR
    J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes.
    Sahu A; Sninsky CA; Kalra SP
    Brain Res; 1997 May; 755(2):339-42. PubMed ID: 9175903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agouti-related protein is a mediator of diabetic hyperphagia.
    Qu SY; Yang YK; Li JY; Zeng Q; Gantz I
    Regul Pept; 2001 Apr; 98(1-2):69-75. PubMed ID: 11179781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
    Dehghani GA; Ahmadi S; Omrani GR
    Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
    J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
    Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats.
    Xie M; Chen D; Zhang F; Willsky GR; Crans DC; Ding W
    J Inorg Biochem; 2014 Jul; 136():47-56. PubMed ID: 24747360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Kuo DY; Yang SF; Chu SC; Chen CH; Chen PN; Hsieh YS
    J Neurochem; 2010 Aug; 114(4):1217-30. PubMed ID: 20533995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
    Dai S; Thompson KH; McNeill JH
    Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased hypothalamic neuropeptide Y messenger RNA levels in two rat models of diabetes.
    Jones PM; Pierson AM; Williams G; Ghatei MA; Bloom SR
    Diabet Med; 1992; 9(1):76-80. PubMed ID: 1551314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic feeding behaviour and changes in hypothalamic galanin and neuropeptide Y gene expression induced by zinc deficiency in the rat.
    Selvais PL; Labuche C; Nguyen XN; Ketelslegers JM; Denef JF; Maiter DM
    J Neuroendocrinol; 1997 Jan; 9(1):55-62. PubMed ID: 9023738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased hypothalamic neuropeptide Y concentrations in diabetic rat.
    Williams G; Steel JH; Cardoso H; Ghatei MA; Lee YC; Gill JS; Burrin JM; Polak JM; Bloom SR
    Diabetes; 1988 Jun; 37(6):763-72. PubMed ID: 3289997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.